Shares in focus: HFCL shares rise 2.5% after reporting 49% drop in annual profit despite strong order book
[ad_1] The shares of HFCL Limited were trading at ₹86.60, up by ₹2.10 or 2.49 per cent on the NSE today at 1.10 pm. HFCL
IndiGo shares rise as brokerages hike targets after strong Q4, Moody’s investment grade rating
[ad_1] The airline’s Q4 EBITDA of ₹5,950 crore came in 13 per cent ahead of estimates, driven by stronger passenger growth of 19 per cent
Zydus Wellness unveils new brand identity amid strong financial growth
[ad_1] Zydus Wellness’ new logo Zydus Wellness, a science-backed FMCG company, today revealed a new corporate brand identity as part of its transformation strategy. The
Borana Weaves IPO enters Day 2 with strong retail interest
[ad_1] The IPO of Borana Weaves enters Day 2 on a strong note with 8.53 times subscription, as retail investors poured in money. The ₹145-crore
CESC Surges Past 200-DMA: Is a Strong Uptrend Underway?
[ad_1] Here’s an interesting stock idea: The stock idea that we have for you today is CESC. The stock has been moving up very gradually
K K Birla’s Avadh, Magadh Sugar report strong Q4 profit growth
[ad_1] | Photo Credit: iStockphoto Post-tax profits of K K Birla sugar companies – Avadh Sugar and Magadh Sugar – registered an increase during the
Medi Assist reports strong FY25 growth with 28.5% profit surge
[ad_1] The shares of Medi Assist Healthcare Services Limited were trading at ₹466.65 down by ₹25.85 or 5.25 per cent on the NSE at 10.25
Markets rally on strong FII buying, trade deal hopes
[ad_1] Markets opened with gains Friday morning, extending yesterday’s rally as positive sentiments were fueled by robust foreign institutional buying, expectations of a US-India trade
Markets set for firm start on strong domestic cues; bulls regain ground
[ad_1] The derivatives market shows a shift toward bullish sentiment, as indicated by rising Put-Call Ratios and positions taken by option writers. | Photo Credit:
Biocon’s businesses at a strong inflection point: MD & CEO Siddharth Mittal
[ad_1] Siddharth Mittal, CEO and Managing Director, Biocon Ltd Pharma major Biocon says its businesses are at a promising inflection point, with strong momentum expected
